AzurRx BioPharma, Inc. Skyrocketed
Fri 22 Jan 21 at 05:30 PM
AzurRx BioPharma, Inc. (AZRX:NASDAQ) rocketted at $1.84, a gain of 48.4%. On Thu 21 Jan 21, AZRX:NASDAQ touched a New 2-Week High of $1.24. The stock appeared on our News Catalysts scanner on Thu 21 Jan 21 at 10:27 AM in the 'BIOTECH' category. From Thu 07 Jan 21, the stock recorded 66.67% Up Days and 30.00% Green Days
About AzurRx BioPharma, Inc. (AZRX:NASDAQ)
AzurRx BioPharma Inc through its subsidiary is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Its products under development includes MS1819 and AZ1101.
Top 10 Gainers:
- Molecular Data Inc. (MKD:NASDAQ), 72.28%
- CLII (CLII:NYSE), 64.92%
- Express, Inc. (EXPR:NYSE), 52.99%
- GameStop Corp. (GME:NYSE), 51.08%
- AzurRx BioPharma, Inc. (AZRX:NASDAQ), 48.39%
- Polar Power, Inc. (POLA:NASDAQ), 47.78%
- Adamis Pharmaceuticals Corporation (ADMP:NASDAQ), 40.94%
- 111, Inc. (YI:NASDAQ), 40.16%
- Asia Pacific Wire & Cable Corporation Limited (APWC:NASDAQ), 35.6%
- YGMZ (YGMZ:NASDAQ), 35.47%